HEPLISAV-B 20 ug/.5mL
Hepatitis B Vaccine (Recombinant) Adjuvanted · INJECTION, SOLUTION · Bamboo US BidCo LLC
HEPLISAV-B is a injection, solution containing hepatitis b vaccine (recombinant) adjuvanted at 20 ug/.5mL, taken intramuscular. Manufactured by Bamboo US BidCo LLC.
Key Facts
- Brand Name
- HEPLISAV-B
- Generic Name
- Hepatitis B Vaccine (Recombinant) Adjuvanted
- NDC Code (Product)
83703-048- Manufacturer
- Bamboo US BidCo LLC
- Strength
- 20 ug/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125428
- Marketing Start
- 01/01/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is HEPLISAV-B used for?
HEPLISAV-B contains Hepatitis B Vaccine (Recombinant) Adjuvanted. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.
Is HEPLISAV-B a controlled substance?
HEPLISAV-B is not classified as a controlled substance by the DEA.
What is the generic name for HEPLISAV-B?
The generic name for HEPLISAV-B is Hepatitis B Vaccine (Recombinant) Adjuvanted. There are no other listed brand versions of Hepatitis B Vaccine (Recombinant) Adjuvanted.
What is the NDC code for HEPLISAV-B 20 ug/.5mL?
The NDC (National Drug Code) for HEPLISAV-B 20 ug/.5mL is 83703-048, listed by Bamboo US BidCo LLC.
Other HEPLISAV-B Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)